Literature DB >> 10591372

From the Food and Drug Administration.

J E Henney.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10591372

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Generic Substitution Issues: Brand-generic Substitution, Generic-generic Substitution, and Generic Substitution of Narrow Therapeutic Index (NTI)/Critical Dose Drugs.

Authors:  Marian Sorin Paveliu; Simona Bengea; Fraga Silvia Paveliu
Journal:  Maedica (Buchar)       Date:  2011-01

2.  Generic substitution of antiepileptic drugs: What's a clinician to do?

Authors:  Michael Privitera
Journal:  Neurol Clin Pract       Date:  2013-04

Review 3.  Bioequivalence criteria for transdermal fentanyl generics: do these need a relook?

Authors:  Carmen Walter; Lisa Felden; Jörn Lötsch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 4.  Bioequivalence; its history, practice, and future.

Authors:  Kamal K Midha; Gordon McKay
Journal:  AAPS J       Date:  2009-10-06       Impact factor: 4.009

5.  Generic substitution: a need for clarification.

Authors:  Gregory M Peterson
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

6.  The Controversy over Generic Antiepileptic Drugs.

Authors:  Susan J Shaw; Adam L Hartman
Journal:  J Pediatr Pharmacol Ther       Date:  2010-04

Review 7.  Requirements for generic antiepileptic medicines: a clinical perspective.

Authors:  Eugen Trinka; Günter Krämer; Martin Graf
Journal:  J Neurol       Date:  2011-06-11       Impact factor: 4.849

Review 8.  Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.

Authors:  Anshika Bakshi; Sandeep C Chaudhary; Mehtab Rana; Craig A Elmets; Mohammad Athar
Journal:  Mol Carcinog       Date:  2017-08-22       Impact factor: 4.784

9.  [Generic drugs: quality, efficacy, safety and interchangeability].

Authors:  Doris Tschabitscher; Peter Platzer; Christoph Baumgärtel; Marcus Müllner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 10.  Requirements for generic anti-epileptic medicines: a regulatory perspective.

Authors:  Marc Maliepaard; Yechiel A Hekster; Arnoud Kappelle; Eugène P van Puijenbroek; André J Elferink; Jan Welink; Christine C Gispen-de Wied; Frits J F Lekkerkerker
Journal:  J Neurol       Date:  2009-07-15       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.